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Protein kinase C isoformsPerﬂuorinated alkyls are widely-used agents that accumulate in ecosystems and organisms because of their
slow rate of degradation. There is increasing concern that these agents may be developmental
neurotoxicants and the present study was designed to develop an avian model for the neurobehavioral
teratogenicity of perﬂuorooctanoic acid (PFOA) and perﬂuorooctane sulfonate (PFOS). Fertilized chicken
eggs were injected with 5 or 10 mg/kg of either compound on incubation day 0. On the day of hatching,
imprinting behavior was impaired by both compounds. We then explored underlying mechanisms involving
the targeting of protein kinase C (PKC) isoforms (α, β, γ) in the intermedial part of the hyperstriatum
ventrale, the region most closely associated with imprinting. With PFOA exposure, cytosolic PKC
concentrations were signiﬁcantly elevated for all three isoforms; despite the overall increase in PKC
expression, membrane-associated PKC was unaffected, indicating a defect in PKC translocation. In contrast,
PFOS exposure evoked a signiﬁcant decrease in cytosolic PKC, primarily for the β and γ isoforms, but again
without a corresponding change in membrane-associated enzyme; this likely partial, compensatory
increases in translocation to offset the net PKC deﬁciency. Our studies indicate that perﬂuorinated alkyls
are indeed developmental neurotoxicants that affect posthatch cognitive performance but that the
underlying synaptic mechanisms may differ substantially among the various members of this class of
compounds, setting the stage for disparate outcomes later in life.HV, intermedial part of the
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Perﬂuorooctanoic acid (PFOA) and perﬂuorooctane sulfonate
(PFOS) are prominent members of the family of perﬂuorinated alkyls
(PFAs). These compounds are widely used for manufacturing non-
stick coatings and stain repellents in fabrics, as well as in food-
packaging and lubricants. PFAs are very poorly biodegradable and are
accumulating in humans and ecosystems worldwide [17], extendingeven to animals in remote locations [10]. Thus, despite recent efforts
to reduce or phase out PFA production [9], these agents will persist in
the environment [20,26].
Parallel to PFA bioaccumulation, toxicological studies in adult rats
given high doses have shown damage to several internal organs,
including the liver, kidneys and heart [43], preceded by substantial
pathological changes in gene expression patterns [12]; parallel
ﬁndings have been reported in zebra ﬁsh [29] and chicks [42]. In
developing rodents, prenatal exposure to perﬂuorooctane sulfonate
(PFOS) compromises survival rates and delays general growth and
development [35]. In chicks, prenatal exposure to PFOS or perﬂuor-
ooctanoic acid (PFOA) elicits reductions in hatchability, interference
with pigmentation and pathological changes in the liver [24,38]. In
our earlier work, we pointed out that the biochemical characteristics
that underlie plumage pigmentation in the chick are also critical for
nervous system development [38], suggesting that the PFAs might be
developmental neurotoxicants, a prediction we conﬁrmed with in
vitro models of neuronal development [30].
Studies in rodents similarly point to behavioral deﬁcits in adulthood
after neonatal exposure to PFOA or PFOS [16], reﬂecting an adverse
impact on functioning of critical neurochemical events required for
synaptic development and function [15]. Nevertheless, rodent models
have inherentmethodological shortcomings fromconfoundingmaternal
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and the so-called “litter effect,” [33], where animals within a given litter
are not independent of each other. Obviously, in the chick model, these
limitations do not apply, since there is nomaternal interaction and every
individual represents an independent sample; further, because the chick
is more mature at hatching than are newborn rats or mice, cognitive
behavior, in the form of imprinting performance, can be evaluated
immediately, prior to any potential impact of prenatal treatment on
feeding or other indirect contributors to behavioral abnormalities. A
newborn chick tends to follow the ﬁrst object it sees after hatching [21]
and can thus be imprinted upon an artiﬁcial object, which then becomes
a suitable subject for studying the effect of prenatal treatments on
imprinting behavior [5,8,31]. We have already demonstrated how this
parallels hippocampus-related visuospatial cognitive performance in
rodents [39], involving in the chick the left intermedial part of the
hyperstriatum ventrale (IMHV) [5,13]; speciﬁcally, cholinergic innerva-
tion in the left IMHV controls the chicks' perception of the imprinting
stimulus [22,36]. Given the postulated involvement of cholinergic
deﬁcits in the long-term neurobehavioral effects of neonatal PFOA and
PFOS exposure in rodents [16], in the present study we evaluated
whether these agents have an adverse effect on imprinting performance
in the chick model.
In addition to behavioral assessments, we also evaluated the
impact of PFOA and PFOS exposure on the concentration of protein
kinase C (PKC) isoforms, which play an integral mechanistic role in
transducing cholinergic input involved in learning and memory.
Speciﬁcally, the translocation of PKC from the cytoplasm to the
membrane is required for imprinting [3,4,25,37]. In our studies, we
obtained the brain samples immediately after the imprinting test so as
to examine the ability of the imprinting stimulus to evoke PKC
translocation. Indeed, in earlier work with other neurotoxicants
known to target cholinergic function, we conﬁrmed the direct
relationship between adverse effects on PKC translocation and
imprinting performance [14]. Here, we identiﬁed different patterns
of effects of PFOA and PFOS on PKC-related mechanisms in association
with impaired imprinting behavior.
2. Methods
2.1. Teratogen treatments
Fertile heterogeneous stock eggs (60±3 g) of the Cobb I chicken
broiler strain (Gallus gallus domesticus) were obtained from a commer-
cial source and placed in an incubator. To introduce substances, a hole
was drilled in the chorioallantois end (pointed end) of the shell and
PFOA and PFOS (Sigma, Israel) were then administered before
commencing incubation, i.e. on incubation day 0 (the PFOA in its free
acid form and the PFOS in its salt form, due to dilution difﬁculties). The
holewas then coveredwith an adhesive silicone glue cap (Medical Type
A; Dow Corning, Midland, MI). Control eggs received equivalent
volumes (1 ml/kg of egg) of corresponding vehicles: saline for PFOA
and TWEEN (polyoxyethylenesorbitan monolaurate, undiluted) for
PFOS. Preliminary studies were conducted over a range of doses (PFOA,
5–40 mg/kg of egg) to choose the optimal treatments that would
produce behavioral defects without decreases in body weight or
increased incidence of leg deformities [38]. The main studies were
then conducted at doses of 5–10 mg/kg of egg for PFOA and PFOS. The
eggs were incubated (model 1202 incubator; G.Q.F. Manufacturing Co.,
Savannah, GA) at 37.5 °C and 50–60% humidity, and were candled on
incubation days 5, 12 and 19. At hatching, morphological and functional
scoring was conducted using a four point scale, developed in our lab: 1.
the chick lays on the ﬂoor 2. the chick stands hunched over and almost
doesn't move 3. the chick shows some locomotion, 4. the chick moves
around, exploring and pecking.
Fourteen to twenty-four hours posthatch, the chicks were trained
to follow an imprinting object and were tested for performance asdescribed below. Afterward, the left IMHVwas removed and taken for
Western blot analysis of the levels of PKC isoforms.
2.2. Induction and testing of imprinting
Asmodiﬁed from earlier descriptions [23], the imprinting apparatus
contained three 20-cmdiameter runningwheelswith the sides covered
in black PVC, permitting the chicks to see only forward or backward. The
imprinting objects were an illuminated red box or a blue cylinder (both
15×10×18 cm high), located 50 cm from the front open side of the
running wheel, lit from within by a 40W bulb with holes covered with
red or blue ﬁlters, and rotated at 30 rpm. The chicks were hatched in
total darkness and handling was done in the dark, aided by a dim green
light, which has a minimal effect on imprinting [19]. All chicks were
tagged and then transferred to an individual dark, enclosed wooden
chamber warmed to 30 °C, where they were physically and visually
isolated from each other. Fourteen to twenty-four hours posthatch, the
chicks underwent 45 min of “priming,” a 30 min exposure to light
(60 Wbulb), followed by15 min of darkness, conductedwhile recorded
maternal calls were played continuously. Immediately afterward, they
were placed individually on the running wheel for 60 min of training
with either blue or red imprinting objects, and the wheel rotations
running toward the imprinting object were recorded. After training, the
chicks were returned to the enclosed chambers for 60 min, after which
testing took place without any additional maternal calls.
There were four testing sessions in counterbalanced, randomized
order, each lasting for 5 min; in twoof the tests, the chickwas allowed to
run toward the imprinting rotating object and, in the other two, toward
the control rotating object. For chicks trained to follow a red object, the
red-light box was used as the imprinting object and the blue light box
served as the control object; for the chicks trained to followablueobject,
these were reversed. Imprinting was then calculated as a preference
score [31]: Preference score=Rotations toward the training light/
(rotations toward the training light+rotations toward the control
light). The expected range of the preference score is 0–1, where 0.5
indicates no imprinting, 1 represents maximal imprinting, and 0
represents avoidance (running away from the imprinted object).
Because this strain of chicken carries a sex-linked early feathering
gene which allows for sexing of the chicks at hatching [11], the chicks'
sex was known immediately following examination; because no
signiﬁcant differences were found, results were pooled for statistical
analysis.
We also assessed locomotor activity of the different experimental
groups (the number of rotations of the wheel made by the chick
during training), since locomotion can by itself inﬂuence imprinting.
The locomotor activity during imprinting testing (both training and
control lights) was expressed as the total number of rotations of the
wheel made by the chick.
2.3. Quantitative assessment of PKC isoforms
After behavioral testing, the brain was removed, and the left IMHV
(2.5–3.0 mg) was quickly dissected [13]. Concentrations of the PKC
isoforms in the cytosolic and membrane fractions of the IMHV were
assayed as described in earlier publications [28,34,41]. Accordingly,
only brief descriptions will be provided here.
The IMHV samples were sliced uniformly, homogenized, and then
sedimented at 100,000×g for 1 h at 4 °C, after which the supernatant
solution containing the cytosolic fraction was frozen. The membrane
pellet was resuspended and digested with 0.5% Triton X-100 (Sigma),
then sedimented as described above, and the supernatant solution
was frozen. Western blot analysis was carried out by gel electropho-
resis of 10–15-µg aliquots of cytosolic and membrane proteins with
speciﬁc primary antibodies for each PKC subtype. Antibodies to
pPKCα and cPKCβII were purchased from Santa Cruz Biochemicals
(Santa Cruz, CA) and PKCγ antibody 36G9, which recognizes chick
Fig. 1. a. Effect of prehatch exposure to PFOA and PFOS on (a) survival and hatching,
(b) bodyweight at hatching and (c)morphological and functional score. Values in (b) and
(c) representmean±SE. Both PFOA and PFOS reduced survival and hatching (pb0.001 by
χ2 test), whereas there were no signiﬁcant differences in weight or morphological and
functional score. Numbers of animals are shown in parentheses.
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IgG HRP-conjugated secondary antibody (Bio-Rad, Hercules, CA) was
used as described earlier [28,41]. As a calibration standard, every gel
contained aliquots of a pooled homogenate combined from all the
samples. This approach was preferable to using a “housekeeping”
protein such as α-tubulin or β-actin, since neuroteratogens are
known to inﬂuence neuromorphological development and thus alter
expression of these cytoskeleton proteins, unrelated to the neurobe-
havioral effects linked to speciﬁc cell signaling pathways [1].
2.4. Data analysis
Data are presented as means and standard errors, with differences
between treatments established by multivariate ANOVA, followed by
Fisher's Least Signiﬁcant Difference test for post hoc comparisons
between groups. Signiﬁcance for all tests was assumed at pb0.05. For
convenience, some results are presented as the percentage change
from control values or as the percentage stimulation over basal PKC
activity; however, statistical tests were always performed on the
original data. Given the two different vehicles used to dissolve PFOA
and PFOS, there were two sets of corresponding controls; further, the
studies involved separate clutches of eggs for each of the PFAs, and
accordingly, each treatment was compared only to its matched
control group.
3. Results
On incubation day 19, fewer of the PFA-exposed eggs contained
developing embryos as compared to the control groups, with
reductions ranging from 30% to 50% (Fig. 1a). In addition, there
were even further reductions in hatchability. However, among the
chicks that hatched, there was no difference in weight (Fig. 1b) nor in
the scoring for general morphology and function (Fig. 1c).
Control chicks showed typically-high imprinting scores [14] of
about 0.8 (Fig. 2a). Chicks exposed to either of the PFAs lost about half
their imprinting ability, although they still showed signiﬁcant
imprinting above the baseline score of 0.5. In general, PFOA had a
greater effect than did PFOS. The effects did not show any sex
preference (no interaction of treatment×sex, not shown), so the
effects of males and females are shown combined. The effects on
imprinting were not secondary to loss of motor function, since overall
activity levels in the imprinting apparatus were not signiﬁcantly
affected (Fig. 2b).
The concentrations of the PKC isoforms in subcellular fractions of
the left IMHV are presented as the percent change from the
corresponding control levels (Fig. 3). Exposure to PFOA produced an
overall increase in cytosolic PKC involving all three isoforms but there
was no corresponding change in membrane-associated PKC (Fig. 3a).
In contrast, PFOS elicited signiﬁcant overall reductions in cytosolic
PKC with a distinct isoform preference of γNβNα; there were no
signiﬁcant effects on membrane-associated PKC.
4. Discussion
In the present study, embryonic exposure to PFOA and PFOS
induced posthatch deﬁcits in imprinting behavior in association with
alterations in the concentrations of PKC isoformswithin the left IMHV,
the brain region in which imprinting is consolidated. Whereas the
behavioral deﬁcits were similar for both PFAs the changes at the
molecular level differed, although as discussed below, the PKC
changes for both agents are consistent with impaired expression
and function of these key intermediates. Because the chick model,
unlike mammalian models, does not involve maternal effects, our
studies indicate that PFAs evoke neurobehavioral teratogenesis
through direct effects on the developing brain, rather than through
indirect compromise of maternal function or maternal–neonatalinteractions; this reinforces conclusions drawn from in vitro models
that similarly point to direct PFA actions on neuronal cell replication
and differentiation [30].
In our previous studies with avian and rodent models, prenatal
exposure to teratogens from different classes of compounds, all
evoked deﬁcits in the ability of PKC isoforms to translocate from the
cytosol to the membrane, in association with their ability to impair
cognitive performance: phenobarbital in the mouse [6]; heroin in the
mouse [18] and chick [14]; and nicotine and the organophosphates,
chlorpyrifos and sarin in the chick [14,40]. We were able to establish a
mechanistic connection between the molecular and behavioral effects
by administering targeted treatments that reversed the deﬁcits
[7,18,28]. Similarly, in the present study with PFOA and PFOS, we
found alterations in PKC expression and translocation paralleling the
behavioral deﬁcits. However, the patterns seen with the PFAs were
distinct from those of the other neuroteratogens. The previously-
Fig. 2. Effect of prehatch exposure to PFOA and PFOS on (a) imprinting performance and
(b) motor activity. Values represent mean±SE. In (a), controls show signiﬁcant
imprinting (pb0.001 compared to the baseline value of 0.5); animals exposed to either
PFOA or PFOS have signiﬁcantly lower scores (pb0.05) than corresponding controls but
still have signiﬁcant imprinting (pb0.05 compared to the baseline value of 0.5).
Numbers of animals are shown in parentheses. There were no signiﬁcant differences in
the total number of wheel rotations (b).
Fig. 3. Effect of prehatch exposure to (a) PFOA and (b) PFOSon PKC in subcellular fractions
of the left IMHV. Scores represent mean±SE of the % change from control concentrations
for each. PFOA produces a signiﬁcant increase in cytosolic PKC (ANOVA main effect,
pb0.0001)without isoform speciﬁcity (no interaction of treatment×isoform); therewere
no signiﬁcant changes in themembrane fraction. PFOS produced a signiﬁcant reduction in
the cytosolic fraction (ANOVAmain effect, pb0.0001), with isoform selectivity of γNβNα
(treatment×isoform, p=0.03). Numbers of animals are shown in parentheses.
185A. Pinkas et al. / Neurotoxicology and Teratology 32 (2010) 182–186studied agents targeted primarily PKCγ, and to a lesser extent, PKCβ,
while largely sparing PKCα, and the deﬁcits were much larger with
respect to themembrane-associated fraction as distinct from cytosolic
PKC [7,14,18,41]. Here, PFOA evoked large increases in the cytosolic
fraction without a corresponding effect onmembrane-associated PKC,
and with little or no selectivity for any of the PKC subtypes. If the
effectiveness of translocation was unaffected by PFOA, then the
membrane-bound PKC should have increased by exactly the same
proportion as for the cytosol; the fact that this did not occur again
points to a defect in the ability to translocate PKC, similar to that seen
with the other neuroteratogens that produce the same behavioral
outcome. Nevertheless, the point remains that PFOA affects a wider
spectrum of PKC subtypes than the other agents, and has unique
effects on cytosolic PKC; PFOA thus may have a wider spectrum of
adverse behavioral effects, a conclusion that clearly needs to be
evaluated in future work.
Although both PFOA and PFOS evoked deﬁcits in imprinting
performance, the effects of PFOS on PKC isoforms differed from those
of PFOA. Instead of causing a global increase in cytosolic PKC
concentrations, PFOS elicited signiﬁcant deﬁcits; as with PFOA, these
were unaccompanied by a corresponding change in the membrane-
associated PKC fraction. Thus, PFOS decreased the cytosolic pool of
PKC available for translocation but there was compensation so that
the relative proportion of membrane translocation was higher,
partially offsetting the drop in total PKC. If this difference from
PFOA is mechanistically connected to the behavioral outcomes, then it
would be expected that PFOS would produce somewhat smaller
deﬁcits, which was in fact the outcome that we observed. By
extension, we would again predict fewer long-term behavioral
deﬁcits with PFOS than with PFOA. The idea that different PFAs
might produce disparate neurodevelopmental outcomes is bolstered
by recent in vitro ﬁndings demonstrating divergent effects on
neuronal cell differentiation, particularly involving the emergence of
the acetylcholine phenotype, the neurotransmitter most closely
associated with imprinting [30]. In any case, the implication is clear
that PFAs cannot simply be regarded as compounds that will all actsimilarly on the developing nervous system but rather, they are likely
to differ substantially in their net effects.
Although both PFOA and PFOS reduced hatchability, this factor
does not translate well from avian to mammalian species. Avian
embryos are extremely sensitive to even minor environmental
perturbations, including vibration and movement, small changes in
temperature and humidity, season, and clutch-to-clutch differences.
In the present study, 20% of the control eggs were infertile or failed to
hatch, a typical percentage for commercial hatcheries. In mammals,
fetal resorption or intrauterine growth retardation occurs only at
toxicant exposures that are considered hallmarks of high-dose
toxicity but the same is not so for avian species, where effects on
hatching often involve lower exposures than those required for
neurobehavioral deﬁcits. Thus, although our results provide inter-
pretable cross-species results for neurodevelopmental endpoints, the
nonspeciﬁc measures, such as hatching rate or malformations are of
limited utility in comparing benchmarks for toxicant exposures.
Another unique feature of the avian model is the fact that the egg is a
closed system. Accordingly, we did not assess the posthatch levels of
186 A. Pinkas et al. / Neurotoxicology and Teratology 32 (2010) 182–186PFOA and PFOS in the present study, but given that fact, combined
with the resistance of these agents to chemical and biochemical
breakdown, the body burden is likely to be the same as that given to
the egg. Nevertheless, it would also be useful to assess the posthatch
persistence of PFOA and PFOS and the relationship to more lasting
neurobehavioral effects.
Production of PFOS in the U.S. was voluntarily discontinued by the
manufacturer in 2002, whereas PFOA continued to bemanufactured for
several additional years [20,26]. Nevertheless, newmembers of the PFA
class continue to emerge [2] and the legacy of the previously-used
compounds will continue because of their long half-lives [20,26]. Our
studies provide some of the ﬁrst evidence that these compounds act
directly as neuroteratogens and that the various members of the PFA
class may differ in their ability to disrupt nervous system development.
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